Chromosomal deletions and tumor suppressor genes in prostate cancer
1Department of Pathology, University of Virginia Health System, Charlottesville 22908, USA. jdong@virginia.edu
Abstract:
Chromosomal deletion appears to be the earliest as well as the most frequent somatic genetic alteration during carcinogenesis. It inactivates a tumor suppressor gene in three ways, that is, revealing a gene mutation through loss of heterozygosity as proposed in the two-hit theory, inducing haploinsufficiency through quantitative hemizygous deletion and associated loss of expression, and truncating a genome by homozygous deletion. Whereas the two-hit theory has guided the isolation of many tumor suppressor genes, the haploinsufficiency hypothesis seems to be also useful in identifying target genes of chromosomal deletions, especially for the deletions detected by comparative genomic hybridization (CGH). At present, a number of chromosomal regions have been identified for their frequent deletions in prostate cancer, including 2q13-q33, 5q14-q23, 6q16-q22, 7q22-q32, 8p21-p22, 9p21-p22, 10q23-q24, 12p12-13, 13q14-q21, 16q22-24, and 18q21-q24. Strong candidate genes have been identified for some of these regions, including NKX3.1 from 8p21, PTEN from 10q23, p27/Kip1 from 12p13, and KLF5 from 13q21. In addition to their location in a region with frequent deletion, there are functional and/or genetic evidence supporting the candidacy of these genes. Thus far PTEN is the most frequently mutated gene in prostate cancer, and KLF5 showed the most frequent hemizygous deletion and loss of expression. A tumor suppressor role has been demonstrated for NKX3.1, PTEN, and p27/Kip1 in knockout mice models. Such genes are important targets of investigation for the development of biomarkers and therapeutic regimens.
Insights
Chromosomal deletions are key early events in cancer, inactivating tumor suppressor genes via various mechanisms. This study identifies critical genes like PTEN and KLF5 in prostate cancer deletions, offering potential biomarker and therapeutic targets.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Chromosomal deletions are frequent early genetic alterations in carcinogenesis.
- These deletions inactivate tumor suppressor genes through mechanisms including loss of heterozygosity, haploinsufficiency, and homozygous deletion.
- The haploinsufficiency hypothesis is valuable for identifying target genes of chromosomal deletions, particularly those detected by comparative genomic hybridization (CGH).
Purpose of the Study:
- To identify and characterize tumor suppressor genes affected by chromosomal deletions in prostate cancer.
- To investigate the roles of specific candidate genes within frequently deleted chromosomal regions in prostate cancer development.
- To explore the potential of these identified genes as biomarkers and therapeutic targets.
Main Methods:
- Analysis of chromosomal regions frequently deleted in prostate cancer.
- Identification of candidate tumor suppressor genes within these regions.
- Evaluation of genetic evidence, functional data, and expression loss for candidate genes.
- Review of existing literature on gene mutations, deletions, and functional roles in prostate cancer models.
Main Results:
- Several chromosomal regions frequently deleted in prostate cancer were identified (e.g., 8p21, 10q23, 13q21).
- Candidate tumor suppressor genes including NKX3.1, PTEN, p27/Kip1, and KLF5 were pinpointed within these regions.
- PTEN showed the highest mutation frequency, while KLF5 exhibited the most frequent hemizygous deletion and expression loss in prostate cancer.
- Tumor suppressor roles for NKX3.1, PTEN, and p27/Kip1 were confirmed in knockout mouse models.
Conclusions:
- Chromosomal deletions play a significant role in prostate cancer initiation and progression by inactivating tumor suppressor genes.
- PTEN, KLF5, NKX3.1, and p27/Kip1 are crucial candidate genes implicated in prostate cancer pathogenesis due to frequent deletions and functional evidence.
- These genes represent promising targets for developing novel diagnostic biomarkers and therapeutic strategies for prostate cancer.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:51Lampbrush Chromosomes
LBCs are made up of two pairs of conjugating homologous chromatids. Each chromatid consists of alternatively positioned regions of condensed-inactive chromatin and loosely placed-active side loops, which can be contracted and extended. The loops...
01:39Chromosomal Theory of Inheritance
02:04Polytene Chromosomes
02:40Chromosome Structure
The centromere is a DNA sequence that links sister chromatids. This is also where kinetochores, protein complexes to which spindle microtubules attach, are constructed after the chromosome is replicated. The kinetochores allow the spindle microtubules to move the chromosomes within the cell during cell division.
Telomeres consist of non-coding repetitive nucleotide...